Research Applications of Mirnite 15 mg
Mirnite 15 mg is a tetracyclic antidepressant compound manufactured by Intas Pharmaceuticals for in-vitro laboratory research. Researchers at Stroid UK Shop investigate mirtazapine for its dual noradrenergic and specific serotonergic antagonist properties in neuropharmacological studies. The compound demonstrates unique receptor binding profiles that distinguish it from other antidepressant classes, making it valuable for examining presynaptic α2-adrenergic receptor antagonism and postsynaptic 5-HT2 and 5-HT3 receptor blockade mechanisms.
Laboratory studies examine mirtazapine’s effects on neurotransmitter systems, particularly its enhancement of central noradrenergic and serotonergic neurotransmission through α2-adrenoceptor antagonism. Research applications focus on histamine H1 receptor interactions, which contribute to the compound’s sedative properties in cellular models. Scientists analyse the drug’s metabolic pathways involving hepatic demethylation and hydroxylation processes, with primary metabolism occurring via CYP1A2, CYP2D6, and CYP3A4 enzyme systems. These pharmacokinetic studies provide insights into drug-drug interaction mechanisms and individual variability in metabolic processing.
Comparative research with other therapeutic classes available in our mirtazapine and other drugs category enables comprehensive neuropharmacological investigations. Laboratory protocols examine the compound’s half-life characteristics, bioavailability parameters, and tissue distribution patterns. Researchers studying mood disorder mechanisms often compare mirtazapine’s receptor profile with compounds from our SARMs and peptides collections to understand different pharmacological approaches to neurochemical modulation. Cell culture studies investigate the compound’s effects on neuroplasticity markers, synaptic protein expression, and neurogenesis pathways in various brain region models.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Mirtazapine |
| Strength | 15 mg per tablet |
| Manufacturer | Intas Pharmaceuticals |
| CAS Number | 85650-52-8 |
| Molecular Formula | C17H19N3 |
| Molecular Weight | 265.35 g/mol |
| Storage Conditions | Room temperature, dry place |
| Shelf Life | As per manufacturer labelling |
Laboratory Research Compliance
Mirnite 15 mg is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines for pharmaceutical compound handling. This product is restricted to qualified research facilities with proper licensing for studying controlled substances and pharmaceutical compounds.
